Loading clinical trials...
Loading clinical trials...
The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melano...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Aura Biosciences
NCT04855435 · Advanced Solid Tumor, Uveal Melanoma, Metastatic, and more
NCT07627698 · Unresectable Melanoma, Metastatic Cutaneous Melanoma, and more
NCT07015190 · Uveal Melanoma
NCT07076550 · Melanoma Metastatic, Uveal Melanoma, Metastatic, and more
NCT06070012 · Uveal Melanoma
Retina Consultants of Alabama
Birmingham, Alabama
UCSD Shiley Eye Institute, Jacobs Retina Center
La Jolla, California
Doris Stein Eye Research Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions